Recent investigations have further emphasized the biological interplay between PD-L1 expression and CD8+ tumor-infiltrating lymphocytes in liposarcomas and other soft tissue sarcomas, underlining their prognostic and therapeutic significance. The gene discussed is CD8A; the disease is soft tissue sarcoma.